Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patient preference for fluticasone furoate vs fluticasone propionate in allergic rhinitis
NCT00398476Phase 3Completed
- Sponsor
- GSK
- Start
- Dec 2006
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fluticasone in allergic rhinitis (AR) (2 arms), sponsored by GSK. Primary endpoint: Overall Participants Preference for Nasal Spray Based on Selected Product Attributes at Day 1. Started Dec 2006; status: completed.
02
Drugs
fluticasone
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT00398476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398476.